Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002047497 | SCV002117338 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2022-09-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004996036 | SCV005598282 | uncertain significance | Cardiovascular phenotype | 2024-12-07 | criteria provided, single submitter | clinical testing | The p.R592Q variant (also known as c.1775G>A), located in coding exon 14 of the JAG1 gene, results from a G to A substitution at nucleotide position 1775. The arginine at codon 592 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |